Kedrion S.p.A.
PolandAll drugs from this manufacturer
-
The medicinal product is used for the treatment and prophylaxis of bleeding in patients with congenital haemophilia A, for the treatment of bleeding in patients with acquired factor VIII deficiency, and in patients with haemophilia who have developed antibodies against factor VIII (inhibitors).
Dosage form: powder and solvent for solution for injection and infusion
Active substance Dosage human coagulation factor viii 500 j.m. ATC: B02BD02
-
The medicinal product is used for the treatment and prophylaxis of bleeding in individuals with congenital haemophilia A, for the treatment of bleeding in individuals with acquired factor VIII deficiency, and for the treatment of haemophiliac patients who have developed antibodies against factor VIII (inhibitors).
Dosage form: powder and solvent for solution for injection and infusion
Active substance Dosage human coagulation factor viii 1000 j.m. ATC: B02BD02
-
The medicinal product is used in adults and children and adolescents for the treatment of antibody deficiencies (replacement therapy) and in the treatment of certain inflammatory diseases, such as immune thrombocytopenia, Guillain–Barré syndrome, Kawasaki disease, chronic inflammatory demyelinating polyneuropathy (CIDP), and multifocal motor neuropathy (MMN).
Dosage form: solution for infusion
Active substance Dosage human normal immunoglobulin for intravenous use 50 mg/ml ATC: J06BA02
-
The medicinal product is used to replenish and maintain circulating blood volume when a deficiency exists and the use of a colloid solution is indicated.
Dosage form: solution for infusion
Active substance Dosage human albumin 131 J ATC: B05AA01
-
The medicine is used to prevent the recurrence of hepatitis B virus after liver transplantation and to prevent infection in people who have had accidental contact with the virus, in patients undergoing hemodialysis, in newborns of mothers who are carriers of the virus, and in individuals for whom vaccination was not effective.
Dosage form: solution for injection
Active substance Dosage human hepatitis b immunoglobulin 180 units ATC: J06BB04
-
The medicinal product is used to prevent reinfection with the hepatitis B virus after liver transplantation and for immediate protection against infection in case of accidental exposure to the virus (in unvaccinated individuals), in patients undergoing hemodialysis, in newborns of mothers who are carriers of the virus, and in individuals for whom vaccination was not effective.
Dosage form: powder and solvent for preparation of infusion solution
Active substance Dosage immunoglobulin human 50 mg/ml antibody anti hbs not less than 50 IU immunoglobulin at least 95% ATC: J06BB04